Evidence map›Paper›PMID 38041982›Full record

SynthesisDrug and alcohol dependence2024

Assessment of substance exposures in nail clipping samples: A systematic review.

Gretchen Bandoli, Florencia Anunziata, Ryan Bogdan, Anna Zilverstand, Barbara H Chaiyachati, Kelly K Gurka, Elinor Sullivan, Julie Croff, Ludmila N Bakhireva

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Drug and alcohol dependence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 1 country.

Gretchen BandoliDepartment of Pediatrics, University of California, La Jolla, San Diego, CA 92093, USA. Electronic address: gbandoli@health.ucsd.edu.
Florencia AnunziataDepartment of Pediatrics, University of California, La Jolla, San Diego, CA 92093, USA.
Ryan BogdanDepartment of Psychological & Brain Sciences, Washington University, St. Louis, MO 63130, USA.
Anna ZilverstandDepartment of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis MN 55455, USA.
Barbara H ChaiyachatiDepartment of Pediatrics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kelly K GurkaDepartment of Epidemiology, Colleges of Public Health & Health Professions and Medicine, University of Florida, Gainesville FL, 32611 USA.
Elinor SullivanDepartment of Psychiatry, Oregon Health & Science University, Portland, OR 97239, USA.
Julie CroffDepartment of Rural Health, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA.
Ludmila N BakhirevaDepartment of Pharmacy Practice & Administrative Sciences, University of New Mexico Health and Health Sciences, Albuquerque, NM 87131, USA.
Oklahoma State University Center for Health Sciences · USOregon Health & Science University · USUC San Diego Health System · USUniversity of California San Diego · USUniversity of Florida · USUniversity of Minnesota · USUniversity of New Mexico · USUniversity of Pennsylvania · USWashington University in St. Louis · US

Funding

The Healthy Brain and Child Development National Consortium Administrative CoreU24DA055325 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTINA CHAMBERS, CHARLES Alexander NELSON · 2021 to 2026
$40.8M
Healthy Brain and Child Development National Consortium Data Coordinating CenterU24DA055330 · NIDA · WASHINGTON UNIVERSITY · PI ANDERS M DALE, Damien A Fair · 2021 to 2026
$34.6M
5/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) ConsortiumU01DA055344 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel, Weili Lin · 2021 to 2026
$13.9M
6/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium VanderbiltU01DA055347 · NIDA · VANDERBILT UNIVERSITY · PI Laurie E Cutting, Sarah Scheiderich Osmundson · 2021 to 2026
$12.7M
5/24 Healthy Brain and Child Development National ConsortiumU01DA055353 · NIDA · BOSTON CHILDREN'S HOSPITAL · PI Michelle A Bosquet Enlow, Patricia Ellen Grant · 2021 to 2026
$12.1M
4/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) ConsortiumU01DA055342 · NIDA · CINCINNATI CHILDRENS HOSP MED CTR · PI STEPHANIE L MERHAR, JENNIFER J. VANNEST · 2021 to 2026
$11.9M
1/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) ConsortiumU01DA055352 · NIDA · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI ASHLEY ACHESON, LORRAINE M MCKELVEY · 2021 to 2026
$11.9M
HEALthy Brain and Child Development Study at UAB and UAU01DA055322 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Rajesh K Kana, Cassandra R. Newsom · 2021 to 2026
$11.2M
23/24 Healthy Brain and Child Development National ConsortiumU01DA055367 · NIDA · WASHINGTON UNIVERSITY · PI RYAN H BOGDAN, CYNTHIA Elise ROGERS · 2021 to 2026
$10.8M
7/24 Healthy Brain and Child Development National ConsortiumU01DA055350 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JAMES J. PEKAR, ANDREW J. SATIN · 2021 to 2026
$10.7M
14/24 The Healthy Brain & Child Development National ConsortiumU01DA055369 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Gretchen E. Bandoli, CARLA B MARIENFELD · 2021 to 2026
$9.7M
2/24 Healthy Brain and Child Development National ConsortiumU01DA055362 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI PAT LEVITT, Beth A Smith · 2021 to 2026
$9.6M
NIAAA NIH HHS K01 AA027811NIDA NIH HHS U01 DA055316NIDA NIH HHS U01 DA055322NIDA NIH HHS U01 DA055338NIDA NIH HHS U01 DA055342NIDA NIH HHS U01 DA055344NIDA NIH HHS U01 DA055347NIDA NIH HHS U01 DA055349NIDA NIH HHS U01 DA055350NIDA NIH HHS U01 DA055352NIDA NIH HHS U01 DA055353NIDA NIH HHS U01 DA055354NIDA NIH HHS U01 DA055355NIDA NIH HHS U01 DA055357NIDA NIH HHS U01 DA055358NIDA NIH HHS U01 DA055359NIDA NIH HHS U01 DA055360NIDA NIH HHS U01 DA055361NIDA NIH HHS U01 DA055362NIDA NIH HHS U01 DA055363NIDA NIH HHS U01 DA055365NIDA NIH HHS U01 DA055367NIDA NIH HHS U01 DA055369NIDA NIH HHS U01 DA055370NIDA NIH HHS U01 DA055371NIDA NIH HHS U24 DA055325NIDA NIH HHS U24 DA055330NIMH NIH HHS K08 MH129657NIMH NIH HHS R01 MH117177NIMH NIH HHS R01 MH124824
6 · The paper itself

Abstract

backgroundStudies of prenatal substance exposure often rely on self-report, urine drug screens, and/or analyses of blood or meconium biomarkers. Accuracy of these measures is limited when assessing exposure over many weeks or months of gestation. Nails are increasingly being considered as a matrix from which to assess substance exposure. This systematic review synthesizes data on the validity of detecting alcohol, nicotine, cannabis, and opioid from nail clippings, with an emphasis on prenatal exposure assessment.

methodsThe systematic review was conducted using PRISMA 2020 guidelines. Seven databases were searched with keywords relevant to the four substances of interest. Results were summarized grouping manuscripts by the exposure of interest with focus on accuracy and feasibility.

resultsOf 2384 papers initially identified, 35 manuscripts were included in our qualitative synthesis. Only a few studies specifically looked at pregnant individuals or mother-child dyads. Across the four substances, many studies demonstrated a dose-response relationship between exposure and concentration of analytes in nails. Nail assays appear to detect lower level of exposure compared to hair; however, sample insufficiency, especially for multi-substance assays, remains a limitation.

conclusionsBased on the reviewed studies, nail clippings are an acceptable and potentially preferable matrix for the evaluation of these four prenatal substances when sampling frequency and/or study design necessitates assessment of past exposures over an extended period. Nails have the advantage of infrequent sampling and minimal invasiveness to assess a broad exposure period. Future studies should examine validity of analytes in toenail versus fingernail clippings.

Indexed as

CannabisNailsFemaleHumansPregnancyAlcoholBiomarkersCannabinoidsKeratinized samplesNailsNicotineOpioidsValidity

Identifiers

PMID38041982
PMCPMC11059950
OpenAlexW4388948224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.